| Eli Lilly and Company discovers, develops, manufactures and sells products in one business segment, pharmaceutical products. The Company also has an animal health business segment. It manufactures and distributes its products through owned or leased facilities in the United States, Puerto Rico and 25 other countries. Eli Lilly and Company's products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production. Its principal products include Neurosciences products, Endocrinology products, Oncology products, Cardiovascular products, Animal health products and Other pharmaceuticals. In August 2008, the Company completed the acquisition of SGX Pharmaceuticals, Inc. In October 2008, Monsanto Company announced that it completed the sale of its POSILAC bovine somatotropin brand and related business to the Company. In November 2008, it completed the acquisition of ImClone Systems Inc. |
